Economic Calendar & Watch List 8/13/2015

1872

Thursday August 13, 2015

 

Economic Calendar & Watch List 8/13/2015

 

Morning Notes

US futures are slightly higher this morning and European stocks are also trading higher by nearly 2% after the People’s Bank of China expressed their support for the Yuan and would “pledge to improve the Yuan’s pricing mechanism. This sparked a rally in global markets overnight. Asian stocks closed higher.

 

Technicals

SPY_8_13

The SPY traded in an extreme range and hitting 1 month lows in yesterday’s session and later bounced back to close green at $208.92. Mid range support will be at the 200 day moving average at $207.59 followed by the low of yesterday’s range at $205.36. Resistance will be at the high of yesterday’s range at $209.14 followed by $209.47.

 

In Play

OHGI: One Horizon – The company announced that it has signed a pact to be the exclusive supplier of Voice over IP services to KeyIdea Information Technology Co., a maker of satellite equipment in China. Gapping up 120% with a 14.7M share float.

BDSI: BioDelivery – The company announced that the FDA Approves New Formulation of Onsolis and sees it returning to the US market in 2016. Gapping up 5% with a 46M share float.

EBIO: Eleven Biotherapeutics – The company posted a Q2 loss wider than expected of $.36 vs the estimate of $.28. However, it is still on a strong move due to the news of the recent eye study and its lead drug candidate. Gapping up 29% with a 7.3M share float.

 

**Others On Watch**

TSLA

GPRO

 

Economic Calendar

08:30 Export Prices (MoM) [Jul] – Consensus (0.10)%

08:30 Import Prices (MoM) [Jul] – Consensus (1.10)%

08:30 Retail Sales (MoM) [Jul] – Consensus 0.50%

08:30 Core Retail Sales (MoM) [Jul] – Consensus 0.40%

08:30 4-Week Jobless Claims Avg. – Consensus 2.206M

08:30 Continuing Jobless Claims Avg. – Consensus 2.206M

08:30 Initial Jobless Claims – Consensus 271K

10:00 Business Inventories – Consensus 0.30 %

 

Earnings Before Open

KSS: Kohls – EPS Est. $1.18, Rev Est. $4.33B

NO COMMENTS

LEAVE A REPLY